A single inhalation dose study to assess efficacy, pharmacokinetics (PK), safety and tolerability of AZD8871 in patients with long-term lung diseases.

Trial Identifier: D6640C00006
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03645434
Start Date: October 2018
Primary Completion Date: August 2019
Study Completion Date: August 2019
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050
Germany Grosshansdof, Germany, 22927
Germany Wiesbaden, Germany, 65187
United Kingdom London, United Kingdom, HA1 3UJ
United Kingdom Manchester, United Kingdom, M23 9QZ